NEW YORK, Nov. 12, 2023 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on developing novel cancer immunotherapies for a broad range of indications, today reported its financial…
SAN FRANCISCO, Nov. 12, 2023 /PRNewswire/ — Verana Health today released a new analysis gathered from the American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) at AAO 2023, the Academy’s annual meeting, taking place in New Orleans, November 12-15. The…
AUSTIN, Texas, Nov. 12, 2023 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers, today announced that on November 11, 2023, it granted option awards to Norman…
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW CALGARY, Alberta, Nov. 12, 2023 (GLOBE NEWSWIRE) — High Arctic Energy…
BEIJING, Nov. 12, 2023 /PRNewswire/ — Since its founding 100 years ago, the Communist Party of China (CPC) has led China to enormous achievements at home and significant contributions to global peace and development. Why was the Party successful in…
ROCK HILL, S.C., Nov. 10, 2023 (GLOBE NEWSWIRE) — 3D Systems (NYSE: DDD) today announced that it proposes to offer $350 million aggregate principal amount of convertible senior notes due 2026 (the “notes”), subject to market conditions and other factors. 3D…
ROCK HILL, S.C., Nov. 10, 2023 (GLOBE NEWSWIRE) — 3D Systems (NYSE: DDD) today announced that it proposes to offer $350 million aggregate principal amount of convertible senior notes due 2026 (the “notes”), subject to market conditions and other factors. 3D…
DET MEST TRANSAKTIONSINTENSIVA ÅRET NÅGONSIN I augusti förvärvades Hela Företagshälsovård, en mindre koncern med inriktning på̊ företagshälsa. Hela är en välrenommerad hälsovårdsverksamhet och passar mycket väl in i vår strategi att förvärva välskötta, stabila och lönsamma, mindre, svenska kvalitetsföretag. Hela…
ISTANBUL, Nov. 12, 2023 /PRNewswire/ — Hepsiburada (NASDAQ: HEPS), a leading Turkish e-commerce platform, today announces a joint performance advertising platform in partnership with Facebook. Managed Partner Ads (MPA) is a next-generation social media advertising platform designed to be used…
ISTANBUL, Nov. 12, 2023 /PRNewswire/ — Hepsiburada (NASDAQ: HEPS), a leading Turkish e-commerce platform, today announces a joint performance advertising platform in partnership with Facebook. Managed Partner Ads (MPA) is a next-generation social media advertising platform designed to be used…
